Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies.

The Stargate Project, a $500B initiative focused on artificial intelligence, lifts AI-driven biotech stocks and an unlikely ...

Most people associate sunburns with DNA damage -- it's what we've been taught in textbooks and by dermatologists for years.

The Stargate Initiative, spearheaded by several tech giants, has raised alarm in the most paranoid parts of the MAGA movement ...

New research reveals that sunburn may be caused by RNA damage, not DNA, challenging long-held beliefs about UV exposure ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...